Immunocore Holdings Ltd (IMCR) — Cash Flow-to-Debt Ratio
Immunocore Holdings Ltd (IMCR) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of $-4.46 Million could theoretically repay 0% of its total liabilities ($705.94 Million) in one year. See Immunocore Holdings Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Immunocore Holdings Ltd Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Immunocore Holdings Ltd across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Immunocore Holdings Ltd.
Annual Cash Flow-to-Debt Ratio for Immunocore Holdings Ltd (2018–2024)
Year-by-year debt coverage analysis for Immunocore Holdings Ltd. Check Immunocore Holdings Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.04x | $26.06 Million | $648.79 Million | ▲ +211.7% |
| 2023 | 0.01x | $2.94 Million | $228.16 Million | ▲ +104.9% |
| 2022 | -0.26x | $-49.21 Million | $187.86 Million | ▲ +67.8% |
| 2021 | -0.81x | $-143.11 Million | $175.76 Million | ▼ -90.7% |
| 2020 | -0.43x | $-60.57 Million | $141.85 Million | ▲ +4.6% |
| 2019 | -0.45x | $-101.38 Million | $226.37 Million | ▼ -274.9% |
| 2018 | -0.12x | $-16.63 Million | $139.19 Million | — |